Sotera Health will release Q2 2025 financial results on August 8, followed by a conference call at 9:00 a.m. EDT.
Quiver AI Summary
Sotera Health Company announced it will release its financial results for the second quarter ending June 30, 2025, before the market opens on August 8, 2025. Following the release, the company will host a conference call at 9:00 a.m. EDT to discuss its financial performance and operational highlights. Interested participants can join the call using specific phone numbers or via a live webcast available on the company's website. A replay of the webcast will be accessible later that day. Sotera Health is recognized as a leading global provider of sterilization solutions and lab testing services, operating through its brands Sterigenics®, Nordion®, and Nelson Labs®.
Potential Positives
- Sotera Health is set to disclose its second-quarter financial results, indicating transparency and accountability to investors.
- The scheduled conference call provides an opportunity for management to directly communicate operational highlights, which can enhance investor confidence.
- The inclusion of a live webcast allows for broader access to financial information, demonstrating the company's commitment to keeping stakeholders informed.
Potential Negatives
- Company's upcoming financial results announcement suggests potential weaknesses in financial performance, raising concerns among investors.
- The announcement lacks specific details about anticipated financial performance, potentially leading to investor uncertainty.
- Schedule of the conference call may indicate the company's need for transparency, possibly due to past scrutiny or challenges in the market.
FAQ
When will Sotera Health release its Q2 2025 financial results?
Sotera Health will release its financial results for the second quarter on August 8, 2025.
What time is the conference call for Sotera Health's financial results?
The conference call will begin at 9:00 a.m. Eastern Daylight Time on August 8, 2025.
How can I access the conference call for Sotera Health?
You can access the call by dialing 1-844-481-2916 or 1-412-317-0709 for international calls.
Will there be a webcast available for the Sotera Health conference call?
Yes, a live webcast will be available on the Company's website under the Investor Relations section.
Where can I find more information about Sotera Health's operations?
Updates about Sotera Health can be found in the Investor Relations section of their website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SHC Hedge Fund Activity
We have seen 102 institutional investors add shares of $SHC stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TPG GP A, LLC added 6,786,110 shares (+inf%) to their portfolio in Q1 2025, for an estimated $79,126,042
- SCULPTOR CAPITAL LP added 4,037,511 shares (+80.8%) to their portfolio in Q1 2025, for an estimated $47,077,378
- ARROWMARK COLORADO HOLDINGS LLC removed 1,483,723 shares (-44.3%) from their portfolio in Q1 2025, for an estimated $17,300,210
- AQR CAPITAL MANAGEMENT LLC removed 1,088,098 shares (-73.3%) from their portfolio in Q1 2025, for an estimated $12,687,222
- JANUS HENDERSON GROUP PLC removed 1,079,452 shares (-13.9%) from their portfolio in Q1 2025, for an estimated $12,586,410
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 1,077,061 shares (-80.4%) from their portfolio in Q1 2025, for an estimated $12,558,531
- MIG CAPITAL, LLC removed 804,626 shares (-13.6%) from their portfolio in Q1 2025, for an estimated $9,381,939
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SHC Analyst Ratings
Wall Street analysts have issued reports on $SHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/24/2025
- Goldman Sachs issued a "Buy" rating on 05/05/2025
To track analyst ratings and price targets for $SHC, check out Quiver Quantitative's $SHC forecast page.
$SHC Price Targets
Multiple analysts have issued price targets for $SHC recently. We have seen 3 analysts offer price targets for $SHC in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $13.0 on 06/24/2025
- Matthew Sykes from Goldman Sachs set a target price of $17.0 on 05/05/2025
- Jason Bednar from Piper Sandler set a target price of $13.0 on 04/23/2025
Full Release
CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the second-quarter ended June 30, 2025 before the market opens on Friday, August 8, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health , along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on August 8 th .
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics
®
, Nordion
®
and Nelson Labs
®
. Sotera Health is committed to its mission, Safeguarding Global Health
®
.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health . For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health .
| Contacts | |
|
Jason Peterson
Vice President, Investor Relations & Treasurer [email protected] |
|
|
Kristin Gibbs
Chief Marketing Officer, Sotera Health [email protected] |
Source: Sotera Health Company
